Why did the Fed cut interest rates today?
How is Tesla addressing door handle safety issues?
What impact does China’s Nvidia chip ban have?
Why was Jimmy Kimmel's show pulled by ABC?
How will Meta's new AI glasses affect the market?
What caused Cracker Barrel’s sales and stock slump?
Why are Starbucks workers suing over new dress code?
Eli Lilly posts full trial data for obesity pill (LLY:NYSE)
seekingalpha.com/news/4495588-eli-lilly-posts-full-trial-data-obesity-pill
Eli Lilly (NYSE:LLY) on Wednesday posted detailed data from its ATTAIN-1 Phase 3 trial for its oral GLP-1 receptor agonist, orforglipron as presented at a European medical event and simultaneously published in The New England Journal of Medicine.
Shares of
This story appeared on seekingalpha.com, 2025-09-17 15:34:36.820000.